National Research Corp
Research National Research Corp (NRC) on Bullrun: valuation model: 56.5% overvalued, market cap USD 487.51M, P/E 88.6, dividend yield 2.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNRC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyUSD
- Valuation signal56.5% overvalued
- Market capUSD 487.51M
- P/E88.6
- Dividend yield2.7%
- Financial periodQ2 2026
- RevenueUSD 35.39M
- Net income-USD 3.28M
- Free cash flowUSD 62.00K
- Gross margin61.7%
Valuation Snapshot
Bullrun's latest valuation model marks National Research Corp as 56.5% overvalued; latest market cap is USD 487.51M; P/E is 88.6; dividend yield is 2.7%.
Peer valuation comparison
Latest P/E is 88.61x versus a Healthcare sector median of 24.46x (262.3% above).
Latest dividend yield is 2.73% versus a Healthcare sector median of 2.11% (29.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 137.39M | USD 11.60M | USD 15.74M | 61.9% | 50 | USD 4.14M | USD 75.02M | USD 13.99M |
| FY2024 | USD 143.06M | USD 24.78M | USD 19.18M | 60.2% | 1.04 | USD 4.23M | USD 57.90M | USD 31.28M |
| FY2023 | USD 148.58M | USD 30.97M | USD 22.33M | 62.3% | 1.25 | USD 6.65M | USD 29.47M | USD 48.96M |
| FY2022 | USD 151.57M | USD 31.80M | USD 26.43M | n/a | 1.27 | USD 25.03M | USD 22.32M | USD 72.03M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 487.51M | 88.6 | 2.7% | 0.6 |
| 2025 | 2025-12-31 | USD 424.90M | 37.5 | 2.8% | 0.52 |
| 2024 | 2024-12-31 | USD 407.19M | 17.0 | 2.7% | 0.48 |
| 2023 | 2023-12-29 | USD 971.53M | 34.1 | 3.7% | 1.48 |
| 2022 | 2022-12-30 | USD 920.98M | 27.0 | 2.3% | 0.84 |
| 2021 | 2021-12-31 | USD 1.05B | 28.4 | 1.2% | 0.48 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.6 USD, yield 2.7%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.52 USD |
| FY2024 | 0.48 USD |
| FY2023 | 1.48 USD |
| FY2022 | 0.84 USD |
About National Research Corp
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is National Research Corp overvalued or undervalued?
Bullrun's valuation model currently marks National Research Corp as 56.5% overvalued.
What is National Research Corp's market cap?
National Research Corp's market capitalization is USD 487.51M.
What is National Research Corp's P/E ratio?
National Research Corp's price-to-earnings (P/E) ratio is 88.6.
Does National Research Corp pay a dividend?
National Research Corp has a dividend yield of 2.7%.
What does National Research Corp do?
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments.